Bevacizumab Pharmacokinetic ELISA Kit

The Bevacizumab ELISA kit is a validated tool for quantifying both Bevacizumab and its biosimilars in biological matrices, facilitating drug research and development. GenScript’s Bevacizumab Pharmacokinetic ELISA Kit has been comprehensively developed and validated for quantitative measurement of Bevacizumab in cynomolgus monkey serum and plasma, based on the ICH M10 and the FDA bioanalytical method validation guidance for industry.

Price	$498.00
Cat. No.	L00969
Size	96 Tests Buy in bulk
Quantity
Est. Delivery


Ask us a question

Product Introduction Bottom Notes

Product Introduction

Linearity Range

39.06-2500 ng/mL (0.78-50 ng/mL diluted)

Sensitivity

ULOQ: 2500 ng/mL
LLOQ: 39.06 ng/mL
HQC of 1875 ng/mL
MQC: 312.5 ng/mL
LQC: 117.18 ng/mL

Precision

Intra-assay: CV≤10%
Inter-assay: CV≤15%

Accuracy

80%-120%

Standard

250 µg/mL of Bevacizumab

Specificity

No cross-reactivity at 25,000 ng/mL of Human IgG1

Assay Temperature

25 ℃

Assay Time

1 h 55 min

Storage

The unopened kit is stable for 12 months from the date of manufacture at 2°C to 8°C, and the opened kit is stable for 1 month from the date of opening at 2°C to 8°C.

Kit Contents

Component	Quantity/Size	Part No.
Capture Plate	1 plate	M1-80
Standard Stock	1 vial (50 μL)	M1-10
Sample Dilution Buffer	1 bottle (60 mL)	M1-60
Biotin Anti-Bevacizumab Antibody	1 bottle (12 mL)	M1-20
Streptavidin-HRP	1 bottle (12 mL)	M1-30
20× Wash Solution	1 bottle (60 mL)	B-A1-71
TMB Solution	1 bottle (12 mL)	B-A1-40
Stop Solution	1 bottle (6 mL)	B-A1-50
Plate Sealer	2 pieces	N/A

Back

Figure 1: Bevacizumab ELISA kit standard curve.
A set of Bevacizumab calibration standards from 39.06 ng/mL to 2500 ng/mL was then diluted with Sample Dilution Buffer with a volume ratio of 1:50. »

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.